Meprobamate

Both a Schedule IV controlled substance prescribed as an anxiolytic and the primary active metabolite of the muscle relaxant carisoprodol, meprobamate requires detection in forensic toxicology investigations for postmortem cases and driving under the influence of drugs (DUID) assessments, pain management compliance monitoring, and emergency department clinical toxicology. UTAK’s Miscellaneous Panel contains meprobamate in lyophilized urine matrix at multiple concentration levels, supporting immunoassay screening and GC-MS or LC-MS/MS confirmation methods. Stock and custom QC solutions can incorporate related analytes such as carisoprodol, benzoylecgonine, cocaine, phencyclidine, THC, zolpidem, and other commonly monitored substances to address your laboratory’s comprehensive drugs of abuse testing requirements.